Medicover AB (publ)
MCVEY · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -17.24 | 2.45 | -2.20 | 0.05 |
| FCF Yield | 5.82% | 4.23% | 1.29% | 7.63% |
| EV / EBITDA | 12.88 | 12.38 | 14.81 | 7.94 |
| Quality | ||||
| ROIC | 2.79% | 2.87% | 2.46% | 8.16% |
| Gross Margin | 21.43% | 20.58% | 22.20% | 28.68% |
| Cash Conversion Ratio | 13.03 | 8.69 | 8.73 | 1.51 |
| Growth | ||||
| Revenue 3-Year CAGR | 11.47% | 8.23% | 14.81% | 17.72% |
| Free Cash Flow Growth | 47.72% | 219.26% | -74.15% | 38.62% |
| Safety | ||||
| Net Debt / EBITDA | 4.22 | 3.70 | 4.17 | 2.48 |
| Interest Coverage | 1.20 | 1.19 | 1.60 | 7.93 |
| Efficiency | ||||
| Inventory Turnover | 23.78 | 23.35 | 20.19 | 13.64 |
| Cash Conversion Cycle | 44.15 | 49.17 | 50.78 | 55.35 |